SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3j2j'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YA4_A_CTXA11_1
(CES1 PROTEIN)
3j2j PROTEIN VP2
(Enterovirus
B)
4 / 8 PRO C  47
LEU C  82
GLY C  81
PRO C 238
None
0.91A 1ya4A-3j2jC:
undetectable
1ya4A-3j2jC:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YA4_B_CTXB1283_1
(CES1 PROTEIN)
3j2j PROTEIN VP2
(Enterovirus
B)
4 / 7 PRO C  47
LEU C  82
GLY C  81
PRO C 238
None
0.92A 1ya4B-3j2jC:
undetectable
1ya4B-3j2jC:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZLQ_A_ACTA1502_0
(NICKEL-BINDING
PERIPLASMIC PROTEIN)
3j2j PROTEIN VP3
PROTEIN VP2

(Enterovirus
B;
Enterovirus
B)
4 / 5 PRO B  54
GLY C 171
ASN C 172
GLY C 169
None
1.19A 1zlqA-3j2jB:
undetectable
1zlqA-3j2jB:
18.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FJ1_A_CTCA222_0
(TETRACYCLINE
REPRESSOR PROTEIN
CLASS D)
3j2j PROTEIN VP1
PROTEIN VP3
PROTEIN VP2

(Enterovirus
B;
Enterovirus
B;
Enterovirus
B)
5 / 12 HIS C 207
PRO C 119
VAL A 187
ILE B  36
SER C 198
None
1.46A 2fj1A-3j2jC:
undetectable
2fj1A-3j2jC:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2J0D_A_ERYA1498_0
(CYTOCHROME P450 3A4)
3j2j PROTEIN VP1
PROTEIN VP3

(Enterovirus
B;
Enterovirus
B)
5 / 12 PHE B  13
PHE A 178
ILE A  33
ALA B  24
ALA A 117
None
1.16A 2j0dA-3j2jB:
undetectable
2j0dA-3j2jB:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QX6_B_ML1B233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])
3j2j PROTEIN VP2
(Enterovirus
B)
4 / 6 GLY C 140
GLY C  84
GLN C  88
PHE C 205
None
1.04A 2qx6A-3j2jC:
undetectable
2qx6B-3j2jC:
undetectable
2qx6A-3j2jC:
19.62
2qx6B-3j2jC:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2TRT_A_TACA222_1
(TETRACYCLINE
REPRESSOR CLASS D)
3j2j PROTEIN VP1
PROTEIN VP2
PROTEIN VP3

(Enterovirus
B)
5 / 11 HIS C 207
PRO C 119
VAL A 187
ILE B  36
SER C 198
None
1.46A 2trtA-3j2jC:
undetectable
2trtA-3j2jC:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VKE_A_TACA222_1
(TETRACYCLINE
REPRESSOR PROTEIN
CLASS D)
3j2j PROTEIN VP1
PROTEIN VP2
PROTEIN VP3

(Enterovirus
B)
5 / 11 HIS C 207
PRO C 119
VAL A 187
ILE B  36
SER C 198
None
1.48A 2vkeA-3j2jC:
undetectable
2vkeA-3j2jC:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XPV_A_MIYA1209_1
(TETRACYCLINE
REPRESSOR PROTEIN
CLASS D)
3j2j PROTEIN VP1
PROTEIN VP2
PROTEIN VP3

(Enterovirus
B)
5 / 12 HIS C 207
PRO C 119
VAL A 187
ILE B  36
SER C 198
None
1.44A 2xpvA-3j2jC:
undetectable
2xpvA-3j2jC:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZIF_B_SAMB298_0
(PUTATIVE
MODIFICATION
METHYLASE)
3j2j PROTEIN VP1
(Enterovirus
B)
5 / 12 ALA A 115
PRO A 116
GLY A 113
LEU A  78
VAL A  77
None
1.21A 2zifB-3j2jA:
undetectable
2zifB-3j2jA:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A51_A_VDYA6178_1
(VITAMIN D
HYDROXYLASE)
3j2j PROTEIN VP3
(Enterovirus
B)
5 / 11 THR B 152
ILE B 132
LEU B 166
VAL B  55
LEU B  85
None
1.22A 3a51A-3j2jB:
undetectable
3a51A-3j2jB:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JW5_B_TOPB208_1
(DIHYDROFOLATE
REDUCTASE)
3j2j PROTEIN VP2
(Enterovirus
B)
5 / 10 ALA C  95
LEU C  77
ILE C  99
LEU C 212
PHE C 210
None
1.15A 3jw5B-3j2jC:
undetectable
3jw5B-3j2jC:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_S_TFPS202_1
(PROTEIN S100-A4)
3j2j PROTEIN VP2
PROTEIN VP3

(Enterovirus
B)
4 / 6 SER B 162
PHE B 120
ILE B 210
PHE C 217
None
1.01A 3ko0S-3j2jB:
undetectable
3ko0S-3j2jB:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TTR_A_LQZA90_1
(LACTOTRANSFERRIN)
3j2j PROTEIN VP2
(Enterovirus
B)
3 / 3 PRO C  44
THR C  45
LEU C 246
None
0.45A 3ttrA-3j2jC:
undetectable
3ttrA-3j2jC:
19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EMA_A_BRLA601_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
3j2j PROTEIN VP2
(Enterovirus
B)
3 / 3 PHE C 217
VAL C 101
ILE C 232
None
0.59A 4emaA-3j2jC:
undetectable
4emaA-3j2jC:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LRH_D_FOLD301_1
(FOLATE RECEPTOR
ALPHA)
3j2j PROTEIN VP1
(Enterovirus
B)
3 / 3 HIS A 161
TRP A 100
SER A  63
None
1.11A 4lrhD-3j2jA:
undetectable
4lrhD-3j2jA:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O8Z_A_BBIA402_1
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL)
3j2j PROTEIN VP1
PROTEIN VP3

(Enterovirus
B)
4 / 5 PHE A  53
PHE A 123
LEU B  25
PRO A  86
None
1.24A 4o8zA-3j2jA:
undetectable
4o8zA-3j2jA:
19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P7N_A_GCSA702_1
(POLY-BETA-1,6-N-ACET
YL-D-GLUCOSAMINE
N-DEACETYLASE)
3j2j PROTEIN VP1
(Enterovirus
B)
3 / 3 ASP A  97
TYR A  98
TRP A 100
None
1.20A 4p7nA-3j2jA:
undetectable
4p7nA-3j2jA:
18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QA0_A_SHHA404_2
(HISTONE DEACETYLASE
8)
3j2j PROTEIN VP2
(Enterovirus
B)
3 / 3 PRO C 194
MET C 193
TYR C  26
None
1.09A 4qa0B-3j2jC:
undetectable
4qa0B-3j2jC:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QA0_B_SHHB404_1
(HISTONE DEACETYLASE
8)
3j2j PROTEIN VP2
(Enterovirus
B)
3 / 3 PRO C 194
MET C 193
TYR C  26
None
1.06A 4qa0A-3j2jC:
undetectable
4qa0A-3j2jC:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V2G_B_CTCB222_0
(TETRACYCLINE
REPRESSOR PROTEIN
CLASS D)
3j2j PROTEIN VP1
PROTEIN VP3
PROTEIN VP2

(Enterovirus
B;
Enterovirus
B;
Enterovirus
B)
5 / 12 HIS C 207
PRO C 119
VAL A 187
ILE B  36
SER C 198
None
1.38A 4v2gB-3j2jC:
undetectable
4v2gB-3j2jC:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V2Z_C_Y70C151_1
(CEREBLON ISOFORM 4)
3j2j PROTEIN VP1
PROTEIN VP2

(Enterovirus
B)
4 / 8 ASN A 132
PHE A 133
PHE A  48
TYR C 176
None
1.35A 4v2zC-3j2jA:
undetectable
4v2zC-3j2jA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V30_B_LVYB151_1
(CEREBLON ISOFORM 4)
3j2j PROTEIN VP1
PROTEIN VP2

(Enterovirus
B)
4 / 8 ASN A 139
PHE A 140
TRP A 137
TYR C 208
None
1.46A 4v30B-3j2jA:
undetectable
4v30B-3j2jA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNW_A_RTZA602_1
(CYTOCHROME P450 2D6)
3j2j PROTEIN VP3
(Enterovirus
B)
5 / 12 PHE B  83
GLY B 188
LEU B  87
VAL B 168
VAL B  55
None
0.98A 4wnwA-3j2jB:
undetectable
4wnwA-3j2jB:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XMF_A_HSMA202_1
(NITROPHORIN-7)
3j2j PROTEIN VP2
(Enterovirus
B)
3 / 3 ASP C  48
LEU C   9
GLY C  10
None
0.54A 4xmfA-3j2jC:
undetectable
4xmfA-3j2jC:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IM2_A_BEZA401_0
(TWIN-ARGININE
TRANSLOCATION
PATHWAY SIGNAL)
3j2j PROTEIN VP3
(Enterovirus
B)
5 / 12 PHE B 118
VAL B  55
ILE B 132
LEU B 116
LEU B  87
None
1.24A 5im2A-3j2jB:
undetectable
5im2A-3j2jB:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VC0_A_RITA602_2
(CYTOCHROME P450 3A4)
3j2j PROTEIN VP1
PROTEIN VP3

(Enterovirus
B)
4 / 7 ILE A  33
LEU B  25
PHE B  28
ARG A  52
None
1.01A 5vc0A-3j2jA:
undetectable
5vc0A-3j2jA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VCG_A_08YA602_1
(CYTOCHROME P450 3A4)
3j2j PROTEIN VP1
PROTEIN VP3

(Enterovirus
B)
5 / 12 PHE B  13
PHE A 178
ILE A  33
ALA B  24
ALA A 117
None
1.20A 5vcgA-3j2jB:
undetectable
5vcgA-3j2jB:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VLM_D_CVID301_0
(REGULATORY PROTEIN
TETR)
3j2j PROTEIN VP1
(Enterovirus
B)
5 / 12 MET A  41
ALA A  10
TYR A 130
VAL A  57
PHE A  59
None
1.39A 5vlmD-3j2jA:
undetectable
5vlmD-3j2jA:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HZP_A_FVTA501_0
(PEPTIDE ABC
TRANSPORTER PERMEASE)
3j2j PROTEIN VP1
PROTEIN VP3

(Enterovirus
B;
Enterovirus
B)
4 / 8 VAL B  94
GLN B  81
ASN A 217
ILE A 216
None
0.86A 6hzpA-3j2jB:
undetectable
6hzpA-3j2jB:
18.61